Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership

$10.15

+0.01 (+0.10%)

(As of 09/20/2024 ET)

Current Insider Ownership Percentage: 9.50%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $200,000.00
Number Of Insiders Selling (Last 12 Months): 4
Amount Of Insider Selling (Last 12 Months): $696,924.17

Get ARQT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARQT Insider Buying and Selling by Quarter

Ad Paradigm Press

Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.

Arcutis Biotherapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/3/2024	Howard G Welgus	Director	Sell	10,000	$10.77	$107,700.00
8/19/2024	Patrick Burnett	Insider	Sell	1,728	$8.29	$14,325.12
8/2/2024	Masaru Matsuda	Insider	Sell	5,220	$9.02	$47,084.40
8/1/2024	Howard G Welgus	Director	Sell	10,000	$9.87	$98,700.00
7/1/2024	Howard G Welgus	Director	Sell	10,000	$9.31	$93,100.00
5/30/2024	Patrick Burnett	Insider	Sell	23,000	$8.75	$201,250.00
"Doomsday indicator” flashing for the first time since the Great Depression... (Ad) It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse... Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>
5/28/2024	Masaru Matsuda	Insider	Sell	1,775	$9.01	$15,992.75
5/17/2024	Larry Todd Edwards	SVP	Sell	7,640	$8.98	$68,607.20
3/4/2024	Masaru Matsuda	Insider	Sell	3,760	$11.12	$41,811.20
1/2/2024	Patrick Burnett	Insider	Sell	1,325	$3.54	$4,690.50
11/21/2023	Masaru Matsuda	Insider	Sell	1,850	$1.98	$3,663.00
10/24/2023	Life Sciences Viii L Frazier	Major Shareholder	Buy	80,000	$2.50	$200,000.00

(Data available from 1/1/2013 forward)

ARQT Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Arcutis Biotherapeutics includes David W Osborne, Howard G Welgus, Larry Todd Edwards, Life Sciences Viii L Frazier, Masaru Matsuda, Orbimed Advisors Llc, Patricia A Turney, Patrick Burnett, Scott L Burrows, and Todd Franklin Watanabe. Learn more on insiders at ARQT.
: 9.50% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings.
: The following insider purchased ARQT shares in the last 24 months: Life Sciences Viii L Frazier ($200,000.00).
: Insiders have purchased a total of 80,000 ARQT shares in the last 24 months for a total of $200,000.00 bought.
: The following insiders have sold ARQT shares in the last 24 months: Howard G Welgus ($903,020.00), Larry Todd Edwards ($68,607.20), Masaru Matsuda ($154,112.15), Patricia A Turney ($50,484.74), Patrick Burnett ($253,704.57), Scott L Burrows ($33,867.60), and Todd Franklin Watanabe ($224,447.17).
: Insiders have sold a total of 142,001 Arcutis Biotherapeutics shares in the last 24 months for a total of $1,688,243.43 sold.